Search Results

There are 30045 results for: content related to: Replicated studies of two randomized trials of angiotensin- converting enzyme inhibitors: further empiric validation of the ‘prior event rate ratio’ to adjust for unmeasured confounding by indication

  1. You have full text access to this OnlineOpen article
    Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 337–350, Kah L. Goh, Krishnan Bhaskaran, Caroline Minassian, Stephen J. W. Evans, Liam Smeeth and Ian J. Douglas

    Version of Record online : 20 JAN 2015, DOI: 10.1111/bcp.12511

  2. You have free access to this content
    Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status

    British Journal of Pharmacology

    Volume 160, Issue 6, July 2010, Pages: 1273–1292, Terry KW Ma, Kevin KH Kam, Bryan P Yan and Yat-Yin Lam

    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00750.x

  3. You have free access to this content
    Treatment of Kidney Transplant Recipients With ACEi/ARB and Risk of Respiratory Tract Cancer: A Collaborative Transplant Study Report

    American Journal of Transplantation

    Volume 11, Issue 11, November 2011, Pages: 2483–2489, G. Opelz and B. Döhler

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1600-6143.2011.03681.x

  4. You have free access to this content
    Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue s3, August 2012, Pages: 1–481,

    Version of Record online : 27 AUG 2012, DOI: 10.1002/pds.3324

  5. You have free access to this content
    Prevention and management of chronic kidney disease in type 2 diabetes

    Nephrology

    Volume 15, Issue s1, April 2010, Pages: S162–S194, Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, Campbell D, Nicholls K, Tong A, Mangos G, Stack A, MacIsaac RJ, Girgis S, Colagiuri R, Colagiuri S and Craig J

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1440-1797.2010.01240.x

  6. You have free access to this content
    Abstracts

    European Journal of Heart Failure

    Volume 18, Issue S1, May 2016, Pages: 8–521,

    Version of Record online : 24 MAY 2016, DOI: 10.1002/ejhf.539

  7. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 7, July 2015, Pages: 795–807, Luděk Červenka, Vojtěch Melenovský, Zuzana Husková, Petra Škaroupková, Akira Nishiyama and Janusz Sadowski

    Version of Record online : 1 JUL 2015, DOI: 10.1111/1440-1681.12419

  8. You have free access to this content
    Preoperative Treatment With an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Receptor Blocker Has No Beneficial Effect on the Development of New-Onset Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery

    Clinical Cardiology

    Volume 35, Issue 1, January 2012, Pages: 37–42, Ji-Hyun Chin, Eun-Ho Lee, Hyo Jung Son, Wook-Jong Kim, Dae-Kee Choi, Soo-Kyoung Park, Ji-Yeon Sim, In-Cheol Choi and Kyung-Don Hahm

    Version of Record online : 21 OCT 2011, DOI: 10.1002/clc.20991

  9. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 3, June 2012, Pages: 335–341, M. C. S. Wong, R. K. C. Lau, J. Y. Jiang and S. M. Griffiths

    Version of Record online : 24 OCT 2011, DOI: 10.1111/j.1365-2710.2011.01300.x

  10. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A221–A237,

    Version of Record online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_1.x

    Corrected by:

    Erratum

    Vol. 13, Issue 2, 335, Version of Record online: 17 DEC 2009

  11. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis

    International Journal of Clinical Practice

    Volume 66, Issue 10, October 2012, Pages: 917–923, J. Cheng, X. Zhang, J. Tian, Q. Li and J. Chen

    Version of Record online : 19 SEP 2012, DOI: 10.1111/j.1742-1241.2012.02970.x

  12. Abstracts of the 21st International Conference on Pharmacepidemiology & Therapeutic Risk Management

    Pharmacoepidemiology and Drug Safety

    Volume 14, Issue S2, September 2005, Pages: S1–S218,

    Version of Record online : 15 AUG 2005, DOI: 10.1002/pds.1136

  13. Abstracts of the 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue S2, July 2007, Pages: S1–S274,

    Version of Record online : 7 AUG 2007, DOI: 10.1002/pds.1461

  14. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 12, December 2014, Pages: 1003–1013, Alexandra Sporková, Šárka Jíchová, Zuzana Husková, Libor Kopkan, Akira Nishiyama, Sung H Hwang, Bruce D Hammock, John D Imig, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Herbert J Kramer and Luděk Červenka

    Version of Record online : 2 DEC 2014, DOI: 10.1111/1440-1681.12310

  15. Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 5, May 2015, Pages: 468–477, Md Jamal Uddin, Rolf H. H. Groenwold, Tjeerd P. van Staa, Anthonius de Boer, Svetlana V. Belitser, Arno W. Hoes, Kit C. B. Roes and Olaf H. Klungel

    Version of Record online : 20 NOV 2014, DOI: 10.1002/pds.3724

  16. You have free access to this content
    Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

    Cardiovascular Therapeutics

    Volume 30, Issue 3, June 2012, Pages: e156–e166, Marsha A. Raebel

    Version of Record online : 26 JAN 2011, DOI: 10.1111/j.1755-5922.2010.00258.x

  17. Invited Presentations

    Nephrology

    Volume 3, Issue S1, May 1997, Pages: S1–S630,

    Version of Record online : 9 NOV 2010, DOI: 10.1111/j.1440-1797.1997.tb00554.x

  18. A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 86–97, Richard Tannen, Dawei Xie, Xingmei Wang, Menggang Yu and Mark G. Weiner

    Version of Record online : 15 OCT 2012, DOI: 10.1002/pds.3360

  19. Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 641–648, Paul L. Hebert, Alexander Marshall McBean, Heidi O'Connor, Barbara Frank, Charles Good and Matthew L. Maciejewski

    Version of Record online : 26 APR 2013, DOI: 10.1002/pds.3449

  20. Prevention of Progression of Kidney Disease

    Nephrology

    Volume 11, Issue s1, April 2006, Pages: S2–S197, DAVID HARRIS, MERLIN THOMAS, DAVID JOHNSON, KATHY NICHOLLS and ADRIAN GILLIN

    Version of Record online : 26 JUN 2009, DOI: 10.1111/j.1440-1797.2006.00505.x